These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 15753645

  • 1. Drugs in clinical development for chronic obstructive pulmonary disease.
    Molfino NA.
    Respiration; 2005; 72(1):105-12. PubMed ID: 15753645
    [Abstract] [Full Text] [Related]

  • 2. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA, Tashkin DP.
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 4. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A.
    Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [Abstract] [Full Text] [Related]

  • 5. Role of bronchodilators in chronic obstructive pulmonary disease.
    Weder MM, Donohue JF.
    Semin Respir Crit Care Med; 2005 Apr; 26(2):221-34. PubMed ID: 16088439
    [Abstract] [Full Text] [Related]

  • 6. [Chronic obstructive pulmonary disease (COPD): diagnosis and treatment].
    Kardos P.
    Dtsch Med Wochenschr; 2004 Mar 05; 129(10):490-3. PubMed ID: 14986237
    [No Abstract] [Full Text] [Related]

  • 7. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul 05; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 8. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA, Donohue JF.
    Semin Respir Crit Care Med; 2010 Jun 05; 31(3):321-33. PubMed ID: 20496301
    [Abstract] [Full Text] [Related]

  • 9. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM, Bollmeier SG, Finnegan PM.
    Ann Pharmacother; 2008 Dec 05; 42(12):1832-42. PubMed ID: 18957624
    [Abstract] [Full Text] [Related]

  • 10. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct 05; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 11. Novel bronchodilators for the treatment of chronic obstructive pulmonary disease.
    Matera MG, Page CP, Cazzola M.
    Trends Pharmacol Sci; 2011 Aug 05; 32(8):495-506. PubMed ID: 21683458
    [Abstract] [Full Text] [Related]

  • 12. [New drug therapy of chronic obstructive pulmonary disease].
    Kino H.
    Nihon Rinsho; 2003 Dec 05; 61(12):2175-80. PubMed ID: 14674329
    [Abstract] [Full Text] [Related]

  • 13. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA.
    Clin Ther; 2007 Oct 05; 29(10):2121-33. PubMed ID: 18042470
    [Abstract] [Full Text] [Related]

  • 14. Corticosteroids: potential beta2-agonist and anticholinergic interactions in chronic obstructive pulmonary disease.
    Johnson M.
    Proc Am Thorac Soc; 2005 Oct 05; 2(4):320-5; discussion 340-1. PubMed ID: 16267356
    [Abstract] [Full Text] [Related]

  • 15. Shortness of breath--is it chronic obstructive pulmonary disease?
    McDonald CF.
    Aust Fam Physician; 2005 Jul 05; 34(7):541-5. PubMed ID: 15999164
    [Abstract] [Full Text] [Related]

  • 16. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct 31; 144(44):55. PubMed ID: 12494604
    [No Abstract] [Full Text] [Related]

  • 17. [Indacaterol is a new once-daily beta2-agonist for treatment of COPD].
    Ulrik CS.
    Ugeskr Laeger; 2010 Nov 22; 172(47):3260-3. PubMed ID: 21092722
    [Abstract] [Full Text] [Related]

  • 18. COPD: current therapeutic interventions and future approaches.
    Barnes PJ, Stockley RA.
    Eur Respir J; 2005 Jun 22; 25(6):1084-106. PubMed ID: 15929966
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic options for chronic obstructive pulmonary disease: present and future.
    Sin DD.
    Eur Rev Med Pharmacol Sci; 2004 Jun 22; 8(6):247-58. PubMed ID: 15745384
    [Abstract] [Full Text] [Related]

  • 20. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
    Beeh KM, Beier J.
    Adv Ther; 2010 Mar 22; 27(3):150-9. PubMed ID: 20411368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.